Zymeworks Stock (NASDAQ: ZYME) stock price, news, charts, stock research, profile.
Open | $8.120 |
Close | $8.260 |
Volume / Avg. | 561.745K / 588.806K |
Day Range | 7.970 - 8.300 |
52 Wk Range | 6.015 - 13.140 |
Market Cap | $582.894M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 8.1% |
Days to Cover | 8.95 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zymeworks (NASDAQ: ZYME) through any online brokerage.
Other companies in Zymeworks’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Korro Bio (NASDAQ:KRRO) and Altimmune (NASDAQ:ALT).
The latest price target for Zymeworks (NASDAQ: ZYME) was reported by Wells Fargo on Tuesday, March 12, 2024. The analyst firm set a price target for 14.00 expecting ZYME to rise to within 12 months (a possible 69.49% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Zymeworks (NASDAQ: ZYME) is $8.26 last updated April 26, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Zymeworks.
Zymeworks’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Zymeworks.
Zymeworks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.